Categories
- Featured (4)
- Multiple Sclerosis Foundation (223)
- National Multiple Sclerosis Society News (212)
- News & Events (1)
- Photos (1)
- Sponsors (14)
- Videos (2)
- WZAK (44)
From The Blog
Recent Posts
- Latest results about emerging MS therapies, risk factors, disease mechanisms, rehabilitation, CCSVI, and much more presented at AAN Meeting
- UPDATE: U.S. FDA and European Medicine Agency Update Prescribing Recommendations for Gilenya to Better Manage Potential Heart Risks at the Time the First Dose Is Taken
- Small Study Reports Benefit of Marijuana on MS Spasticity
- Speeding Clinical Trials for People with Progressive MS: Outcomes Published from an International Workshop on MS Disability Measurement Tools
- FDA Issues Safety Communication About Procedures to Treat CCSVI in People with MS
